The case for induced pluripotent stem cell‐derived cardiomyocytes in pharmacological screening

Publisher: John Wiley & Sons Inc

E-ISSN: 1476-5381|169|2|304-317

ISSN: 0007-1188

Source: BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.169, Iss.2, 2013-05, pp. : 304-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract